A Study to Evaluate the Safety and Efficacy of Oral Nizubaglustat (AZ-3102) in Late-infantile and Juvenile Forms of Niemann-Pick Type C Disease (NPC)

Clinical trial NCT07082725 · RECRUITING

Trial details

NCT number: NCT07082725
Sponsor: Azafaros B.V.
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Niemann-Pick Type C Disease

Start date: 2025-06-30
Primary completion: 2028-05-14
Enrollment: 72

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.